The Drug Enforcement Administration has deemed modafinil a schedule IV drug; other stimulants used to treat ADHD, such as Ritalin, are schedule II.
Despite potential advantages, the panel did not want modafinil to be marketed for children yet.
“I think we did err on the side of consumer protection,” said Dr. Goodman.